Sentinus, LLC Northwest Biotherapeutics Inc Transaction History
Sentinus, LLC
- $293 Million
- Q2 2024
A detailed history of Sentinus, LLC transactions in Northwest Biotherapeutics Inc stock. As of the latest transaction made, Sentinus, LLC holds 12,925 shares of NWBO stock, worth $4,265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,925Holding current value
$4,265% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding NWBO
# of Institutions
15Shares Held
688KCall Options Held
0Put Options Held
0-
Moloney Securities Asset Management, LLC424KShares$140,0220.03% of portfolio
-
Opus Capital Group, LLC60.2KShares$19,8490.0% of portfolio
-
Maripau Wealth Management LLC Fort Wayne, IN39.5KShares$13,0320.01% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY35KShares$11,5500.0% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA23.7KShares$7,8210.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $342M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...